And, outsmarting new tick-borne viruses.

Get full access to Reuters.com for just $1/week. Subscribe now.

 

Health Rounds

Health Rounds

By Nancy Lapid, Health Science Editor

Hello Health Rounds readers! Today we report on two promising early-stage achievements: 3D-printing of experimental customized contact lenses, and characterization of the defenses employed by an emerging tick-borne virus.

Breaking news in the US...  FDA examines produce items in US cyclosporiasis outbreak as cases rise – and what you need to know about the outbreak; US appeals court revives hundreds of private lawsuits linking Tylenol to autism; pollution from Musk’s unpermitted xAI power project hits hardest in Black communities; pesticide makers stack wins against US environmental, public health groups; US judge won't block FTC case against transgender health nonprofit; and US to block citizens in Congo from immediate travel home, citing Ebola.

And elsewhere: WHO has less than half funding needed to fight Ebola; Nigeria to lead internal humanitarian response as UN support evolves; New Zealand study finds nitrates in drinking water may cause 120 premature births a year; Congo's Ebola outbreak spreads to two more provinces; German hospital treats US Ebola patient; and Europe recorded 10,000 excess deaths during June heatwave.

 

Industry Updates

  • CVS agrees to count TrumpRx drug purchases towards insurance.
  • Trial of Gilead's experimental Bundibugyo antiviral begins.
  • Spero licenses Innovent experimental immune disease drug.
  • AstraZeneca to license lung cancer drug from Dizal Pharma.
  • US appeals court revives Teva lawsuit over Lilly osteoporosis drug.
  • FDA OK's at-home starter dose of Eisai-Biogen Alzheimer's drug.
  • Mylan to sell up to $363 million stake in India's Biocon.
  • Oxford begins first human trial of Bundibugyo Ebola vaccine.
  • China Medical System to pay Insilico for nervous system work.
  • Sleep apnea pill maker Apnimed files for US IPO.
 
 

Inside RFK Jr.’s push to dismantle decades of U.S. vaccine policy

REUTERS/Kevin Lamarque

Insider accounts reveal the scale of the U.S. health secretary's ambitions to curb childhood immunizations and unearth a link between vaccines and autism.

 

Study Rounds

Customized 3D-printed contact lenses come closer to reality

 

Made-to-order rigid contact lenses could one day be produced by 3D printers in as little as 20 minutes, researchers say.

That means customized lenses could someday be designed, manufactured and dispensed during a single visit to the optometrist, according to a report in Materials & Design.

“We are very excited about this work because it brings us closer to contact lenses that are truly personalized," study leader Dr. Shirley Tang of the University of Waterloo in Ontario said in a statement.

"Our technology produces lenses with patient-specific surfaces for a precise fit while delivering the optical clarity and mechanical performance expected of commercial contact lenses.”

The inner surface of the lens will precisely match the patient's cornea and the outer surface will be shaped to provide the required vision correction, her team said.

Silicone – the conventional material used in contact lenses – is generally not compatible with 3D printing, so the researchers developed a new silicone formulation.

Because 3D-printed objects are built layer by layer, tiny stair-step imperfections can form on curved surfaces and reduce optical clarity and wearer comfort. To address this issue, the team developed an ultra-thin, non-contact coating process that smooths the surface without altering the customized shape of the lens or compromising its optical performance.

The lenses have so far been tested only in lab experiments. The researchers have filed a provisional patent for their hydrophilic silicone material and are preparing to test the lenses in actual eyes.

The project received a Gold Medal at the Shanghai International Exhibition of Inventions in June 2026.

 

Read more about health applications of 3D printing on Reuters.com

  • Space station bioprinting experiment advances quest for lab-grown tissues, company says
  • Health Rounds: 3D printed insulin-producing cells show promise for type 1 diabetes in lab tests
  • Health Rounds: Ultrasound triggers experimental 3D drug-delivery implants
 

Scientists prepare to fight emerging tick-borne viruses

New research is shedding light on how an emerging class of tick-borne viruses manages to evade the human immune system, in discoveries that researchers hope will lead to preventive methods and treatments.

Several so-called nairoviruses are carried by ticks that bite humans and can cause high fevers and impair organ function, researchers reported in ACS Infectious Diseases.

The Crimean-Congo hemorrhagic fever virus, for example, is often fatal and is a threat to people in Africa, the Middle East and Asia.

Scientists already know that some nairoviruses evade the immune system by producing enzymes that make them undetectable. The enzymes remove small proteins attached to human proteins that would have alerted the immune system to an infection.

For the current study, researchers wanted to see whether this was true of some newly identified nairoviruses, including one called PCTNV that’s so far been found in ticks on the U.S. Pacific Coast but not in humans.

Their experiments suggested that PCTNV might be well equipped to evade the human immune system using these enzymes – and because PCTNV is carried by a human-biting tick already known to transmit Rocky Mountain spotted fever, people along the U.S. West Coast could be at risk for exposure.

“This study reinforces the need to be vigilant about not just tick bites but the type of ticks that an individual has been bitten by as they may carry diseases beyond what we have been used to looking for,” study leader Scott Pegan of the University of California, Riverside said in a statement.

Learning how these viruses skirt host immunity will aid development of countermeasures and biosurveillance tools, he added, noting that his team has been able to train computers to identify disease-causing nairoviruses using models that could ultimately contribute to a biosurveillance system.